Vitamin D supplementation may improve biochemical end points in CKD patients, but whether such improvements translate into clinically significant outcomes is still unknown, according to a systematic review and meta-analysis presented at Renal Week 2010 in Denver.
Cinacalcet appears to be safe and effective for long-term use in the treatment of secondary hyperparathyroidism (SHPT) in peritoneal dialysis (PD) patients, according to a new study presented at Renal Week 2010 in Denver.
African-Americans (AAs) appear to have more severe vitamin D deficiency and elevations of parathyroid hormone (PTH) across all stages of CKD compared with other races, according to researchers at the University of Chicago who presented their study at Renal Week 2010 in Denver.
Please login or register first to view this content.
